XML 27 R14.htm IDEA: XBRL DOCUMENT v3.25.1

Internal Use Software Development Costs

12 Months Ended

Dec. 31, 2024

Research and Development [Abstract]

Internal Use Software Development Costs

Note 5 – Internal Use Software Development Costs

Internal Use Software Development Costs consisted of the following:

 Schedule of Internal Use Software Development Costs

										Estimated Useful
Type		December 31, 2024				December 31, 2023				Life (Years)
Internal use software development costs		$	668,484			$	668,484			3
Less: accumulated amortization			(351,890	)			(129,060	)
Less: impairment loss			(316,594	)			-
Internal Use Software Development Costs - net		$	-			$	539,424

Costs incurred for Internal Use Software Development Costs

Management has determined that all costs incurred in 2023 ($281,304) related to internal software development costs related to the application and infrastructure development stage were completed as of December 31, 2023. Amortization of these costs began in 2024.

Management determined that all costs incurred in 2022 ($387,180) related to internal use software development costs related to the application and infrastructure development stage which were completed as of December 31, 2022. Amortization of these costs began in 2023.

At December 31, 2024, the Company determined that there was no future use for its capitalized internal use software development costs based upon its current and expected future operations. As a result, the Company recorded an impairment loss of $316,594 and removed the gross amount of its capitalized costs totaling $668,484. See Note 1.

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

The following is a summary of our capitalized internal use software development costs at December 31, 2024 and December 31, 2023:

 Schedule of Capitalized Internal Use Software Development Costs

Balance - December 31, 2022		$	387,180
Capitalized costs			281,304
Balance - December 31, 2023			668,484
Impairment loss			(668,484	)
Balance - December 31, 2024		$	-

For the years ended December 31, 2024 and 2023, amortization of internal software development costs was $222,830 and $129,060, respectively.

X

- References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 985
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/985-20/tableOfContent

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 730
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483041/730-20-50-1

+ Details

Name:	us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration